Zivo Bioscience (ZIVO) Stock Statistics & Valuation Metrics

Zivo Bioscience has a market cap or net worth of $70.69M. The enterprise value is ―.

Zivo Bioscience has 3,759,213 shares outstanding. The number of shares has decreased by -2.65% in one year.

Zivo Bioscience’s return on equity (ROE) is 3.53 and return on invested capital (ROIC) is 390.59%.

The current PE Ratio of Zivo Bioscience is -0.26. Zivo Bioscience’s PEG ratio is 0.01.

In the last 12 months, Zivo Bioscience had revenue of 27.65K and earned -7.78M in profits. Earnings per share was -4.60.

In the last 12 months, operating cash flow was -4.12M and capital expenditures 0.00, giving a free cash flow of -4.12M billion.

Zivo Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Zivo Bioscience upcoming earnings date is Mar 15, 2024, TBA Not Confirmed.

Zivo Bioscience as a current ratio of 0.15, with Debt / Equity ratio of -1.06%

In the past 12 months, Zivo Bioscience has paid 0.00 in taxes.

Zivo Bioscience EV to EBITDA ratio is -0.29, with an EV/FCF ratio of -0.36.

Zivo Bioscience has $159.40K in cash and marketable securities with $18.15M in debt, giving a net cash position of -$137.38K billion.

Gross margin is 33.01%, with operating margin of -26267.67%, and net profit margin of -28127.25%.

The average price target for Zivo Bioscience is ―, which is 11.43% higher than the current price. The consensus rating is Hold